B-cell non-Hodgkin lymphoma
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study
17
The therapeutic effectiveness of 177Lu-lilotomab in B-cell non- Hodgkin lymphoma involves modulation of G2/M cell cycle arrest
15
Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells
17
Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study
9
Concomitant nodal involvement by Langerhans Cell Histiocytosis and Hodgkin Lymphoma
1
Calcium Independent Effect of Orai1 and STIM1 in Non-Hodgkin B Cell Lymphoma Dissemination
18
Pro-apoptotic effect of doxycycline and hydroxychloroquine on B-cell lymphoma induced by C. burnetii
3
en fr PATHOLOGICAL ROLE OF CHROMOSOME 1 PERICENTROMERIC HETEROCHROMATIN ANOMALIES IN NON-HODGKIN B-CELL LYMPHOMA ROLE PATHOLOGIQUE DES ANOMALIES DE L'HETEROCHROMATINE PERICENTROMERIQUE DU CHROMOSOME 1 DANS LES LYMPHOMES B MALINS NON-HODGKINIENS
230
In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas
11
Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma
7
en fr Social inequalities impacts of care management and survival in patients with non-hodgkin lymphoma Rôle des inégalités sociales dans la prise en charge et la survie des lymphomes non hodgkiniens en population générale
230
Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.: Molecular Signature of Hepatosplenic T-cell Lymphoma
41
Gene expression-based risk score in diffuse large B-cell lymphoma.
12
Increased activation of PI3 kinase-δ predisposes to B cell lymphoma.
17
A transcriptional signature associated with non-Hodgkin lymphoma in the blood of patients with Q fever
19
Cytolytic T-cell response to the PASD1 cancer testis antigenin patients with diffuse large B-cell lymphoma
12
Results from the Belgian mantle cell lymphoma registry
8
Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma
20
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus
11
Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis
13